TechnoPhage
PrivateLast Round
Grant
Jul 25, 2022
Total Funding Raised
$5.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
TechnoPhage operates in Healthcare & Life Sciences and is based in Lisbon. Its latest recorded funding round was a Grant round in July 2022.
TechnoPhage is a biotechnology and drug discovery company that develops innovative therapies for unmet medical needs in infection, neurosciences, and ophthalmology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TechnoPhage Comparables
Compare TechnoPhage with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BiomX Inc. | 79% | |
| NexaBiome | 78% | |
| PHAXIAM Therapeutics S.A. | 78% |
For institutional investors. Book with your work email.
TechnoPhage Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 25, 2022 | ||||
| Accelerator | Jan 1, 2020 | ||||
| Grant | Feb 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
TechnoPhage Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission | Grant |
| Portuguese Government | Grant |
| Johnson & Johnson Innovation - JLABS | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 66% MoM.
- Feb 21, 2026
Grew 15% QoQ from 26 to 30 employees.
For institutional investors. Book with your work email.
TechnoPhage Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TechnoPhage's valuation, stock price, and market status.
Is TechnoPhage a public or private company?
TechnoPhage is a private company.
What is the current stock price of TechnoPhage?
TechnoPhage is a private company, so its shares have no public market price. Caplight tracks TechnoPhage's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TechnoPhage worth (valuation)?
Valuation information for TechnoPhage is not publicly available.
Can I buy TechnoPhage stock?
TechnoPhage shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TechnoPhage's last funding round?
TechnoPhage's most recent funding round was Grant on July 25, 2022.
Who are the main investors in TechnoPhage?
Key investors in TechnoPhage include European Commission, Portuguese Government, Johnson & Johnson Innovation - JLABS.
Will TechnoPhage IPO soon?
No public IPO plans have been announced for TechnoPhage.
How can I track TechnoPhage secondary market activity?
Caplight tracks bids, offers, and trades in TechnoPhage's shares on secondary markets.